Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioAlliance reports positive results of cancer biotherapy
The new results demonstrate the efficacy of Amep when administered intramuscularly. Amep prompted a 53% reduction in tumor growth (proof of concept established in a melanoma model). Amep,
The new results demonstrate the efficacy of Amep when administered intramuscularly. Amep prompted a 53% reduction in tumor growth (proof of concept established in a melanoma model). Amep,
In the ongoing Phase II trial, the efficacy and safety of intravenous picoplatin (120mg/m squared) administered every 21 days in combination with full-dose docetaxel (75mg/m squared) with daily
The primary objectives of the Phase I open-label, dose-escalation study are to evaluate the safety and tolerability of HGS1029 as monotherapy in patients with advanced solid tumors, and
This three-arm, open-label, randomized, Phase III trial compared two different dose regimens of Torisel with investigators’ choice of therapy (IC) in patients with relapsed or refractory mantle cell
This effort includes an immediate workforce reduction of approximately 15% through attrition and termination of positions as well as a decrease in other expenses through improved operational efficiencies
The head-to-head study compared rivaroxaban with the US-approved dosing regimen for enoxaparin, the current standard of care, for the prevention of venous thromboembolism (VTE) following total knee replacement
In the pivotal study conducted in Quebec, Canada, patients with LPL-deficiency were first enrolled in an observation study and subsequently treated in a study in which there are
The Committee for Medicinal Products for Human Use (CHMP) recommends the use of Erbitux in the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic
According to the company, the DL900’s advanced technology platform has the capacity to support numerous original equipment manufacturers capabilities, including multi parameter recording and data storage of a
The Phase I trial enrolled 16 patients with advanced solid tumors who had received up to three prior regimens for metastatic disease. Patients were administered picoplatin followed by